New York State Common Retirement Fund’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
SP
DTC
ACA
TAM
AC
FLSM
AAA
New York State Common Retirement Fund's AUTL Position: Q3 2024 in Review
New York State Common Retirement Fund sold out of Autolus Therapeutics (AUTL) in Q3 2024, closing a stake of 10,111 shares — an estimated $35.2K sold.
New York State Common Retirement Fund first reported a position in AUTL in Q2 2018 and held it in 16 quarters. The position peaked at $448K in Q2 2020. 101 funds tracked by Wall St. Rank hold AUTL as of Q3 2024.
- New York State Common Retirement Fund reported no remaining Autolus Therapeutics position as of Q3 2024 after selling out during the quarter.
- New York State Common Retirement Fund sold 10,111 Autolus Therapeutics shares in Q3 2024, an estimated $35.2K.
- New York State Common Retirement Fund first reported a position in Autolus Therapeutics in Q2 2018 and held it in 16 quarters.
- New York State Common Retirement Fund's Autolus Therapeutics position peaked at $448K in Q2 2020.
- 101 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2024.
Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.